Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSA.L Regulatory News (SSA)

  • There is currently no data for SSA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sistema PJSFC: Binnopharm Group increases stake in Sintez to 88.6%

12 May 2021 08:00

Sistema PJSFC (SSA) Sistema PJSFC: Binnopharm Group increases stake in Sintez to 88.6% 12-May-2021 / 10:00 MSK Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Binnopharm Group increases stake in Sintez to 88.6%

12 May 2021, Moscow - Sistema PJSFC ("Sistema", the "Corporation" or, together with its subsidiaries and affiliates, the "Group") (LSE: SSA, MOEX: AFKS), a publicly traded Russian investment company, announces that its fully owned subsidiary LLC Sistema Telecom Assets has contributed its 32.4% stake in OJSC Sintez to the authorised capital of LLC Binnopharm Group. Following the transaction, Binnopharm Group has increased its stake in OJSC Sintez to 88.6%.

As a result, the effective stake in Binnopharm Group owned by Sistema together with VTB, Sistema's financial partner in the development of the pharmaceuticals business, now stands at 86.5%. A consortium of investors consisting of the Russian Direct Investment Fund ("RDIF"), the Russia-China Investment Fund (co-founded by RDIF and China Investment Corporation) and leading Middle Eastern funds holds 12.5%, with the remaining 1% owned by a minority shareholder (an individual). 

Binnopharm Group is a full-cycle Russian pharmaceutical holding company that combines five production sites across Russia: JSC Alium (formerly OBL Pharm; Serpukhov district, Moscow region), JSC Binnopharm (two sites at Zelenograd and Krasnogorsk), JSC Sintez (Kurgan) and JSC Biocom (Stavropol). Binnopharm Group companies produce a wide range of drugs in various therapeutic groups and have the largest portfolio of drugs among Russian manufacturers with more than 450 marketing authorisations, including the COVID-19 vaccine Sputnik V.

***

For further information, please visit www.sistema.ru or contact:

Press Service of Sistema

Sergey Kopytov

Phone: +7 (495) 228 15 32

kopytov@sistema.ru

IR Service

Nikolai Minashin

Phone: +7 (495) 730 66 00

n.minashin@sistema.ru

 

Sistema PJSFC is a publicly traded Russian investment company with a diversified portfolio of assets serving over 150 million customers in the sectors of telecommunications, high technology, financial services, retail, paper and packaging, agriculture, real estate, tourism and medical services. The company was founded in 1993. Revenue in 2020 was RUB 691.6 billion; total assets equalled RUB 1.4 trillion as of 31 December 2020. Sistema's global depositary receipts are listed under the "SSA" ticker on the London Stock Exchange. Sistema's ordinary shares are listed under the "AFKS" ticker on the Moscow Exchange. Website: www.sistema.com.

 

 


ISIN:US48122U2042
Category Code:MSCH
TIDM:SSA
LEI Code:213800JSZ2UUK4QQK694
Sequence No.:104444
EQS News ID:1195434
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Dec 20217:00 amEQSSistema PJSFC: Sistema announces financial results for the third quarter 2021
29th Nov 20214:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
22nd Nov 20214:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
15th Nov 20214:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
8th Nov 20214:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
1st Nov 20214:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
25th Oct 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
18th Oct 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
11th Oct 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
11th Oct 20217:04 amEQSSistema PJSFC: Sistema to partially monetize its stake in Segezha Group
4th Oct 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
27th Sep 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
22nd Sep 20215:55 pmEQSSistema PJSFC: Director/PDMR Transaction
20th Sep 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
20th Sep 20214:35 pmRNSPrice Monitoring Extension
16th Sep 20216:00 pmEQSSistema PJSFC: Sistema to divest Sistema Capital LLC
15th Sep 20215:30 pmEQSSistema PJSFC: Announcement on the acquisition of Nearmedic Group
13th Sep 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
30th Aug 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
30th Aug 20218:00 amEQSSistema PJSFC: Sistema announces financial results for the second quarter 2021
27th Aug 20214:29 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
16th Aug 20215:05 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
9th Aug 20215:03 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
2nd Aug 20215:50 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
26th Jul 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
19th Jul 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
12th Jul 20215:50 pmEQSSistema PJSFC: Director/PDMR Transaction
12th Jul 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
5th Jul 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
2nd Jul 20214:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
1st Jul 20216:00 pmEQSSistema PJSFC: Director/PDMR Transaction
29th Jun 20216:00 amEQSSistema PJSFC: VTB Capital invests in Binnopharm Group
28th Jun 20215:50 pmEQSSistema PJSFC: Director/PDMR Transaction
28th Jun 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
28th Jun 20218:00 amEQSSistema PJSFC: Sistema announces decisions of AGM and Board of Directors
25th Jun 20215:28 pmEQSSistema PJSFC: Fitch Ratings upgrades Sistema's credit rating to BB
21st Jun 202111:18 amEQSSistema PJSFC: Report on Payments to Governments for 2020
16th Jun 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
15th Jun 202110:00 amEQSSistema PJSFC: Sistema increases the volume of its share buyback programme
15th Jun 20218:00 amEQSSistema PJSFC: Sistema announces financial results for the first quarter 2021
11th Jun 20217:47 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
7th Jun 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
4th Jun 20215:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
3rd Jun 20215:55 pmEQSSistema PJSFC: Director/PDMR Transaction
3rd Jun 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
1st Jun 20217:45 amEQSSistema PJSFC: Ad-Hoc Notice
31st May 20215:23 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
26th May 20215:55 pmEQSSistema PJSFC: Director/PDMR Transaction
26th May 20215:00 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
24th May 20214:00 pmEQSSistema PJSFC: Sistema announces new dividend policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.